Plain-English translation of NCT07082608 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a minimally invasive procedure called Endoscopic Sleeve Gastroplasty (ESG) — which reduces stomach size to help with weight loss — works better than lifestyle changes alone for people with sleep apnea and obesity. Half of the participants will receive the ESG procedure along with a structured diet and exercise program, while the other half will follow the diet and exercise program without the procedure. The study will measure whether this treatment combination improves sleep apnea symptoms and overall health over 12 months.
Obesity is a major cause of obstructive sleep apnea, a serious condition where breathing repeatedly stops during sleep. Early research suggests that the ESG procedure combined with weight loss may relieve sleep apnea more effectively than diet and exercise alone, but more evidence is needed to confirm this.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups: one group receives the ESG procedure under anesthesia plus a structured program with a 1200–1500 calorie daily diet, 150 minutes of moderate exercise per week, and behavioral counseling; the other group follows the same diet and exercise program without the procedure. You will have office visits at regular intervals throughout the study to measure your weight, sleep apnea severity, sleep quality, and general health. The study lasts at least 12 months, with some participants followed for 24 months to see how long the benefits last.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
India